A retrospective evaluation of the effect of hydroxyquinine on RPE thickness

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 251, Issue 7, 2013, Pages 1687-1690

  Pikkel, Joseph ^a,b   Chassid, Otzem ^a   Sharabi Nov, Adi ^a,c   Beiran, Itchak ^d,e  

^a Rebecca Sieff Government Hospital   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c TEL HAI COLLEGE   (Israel)

^d RAMBAM MEDICAL CENTER   (Israel)

^e TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Age related macular degeneration (AMD); Hydroxychloroquine; Optical Coherence Tomography (OCT); Plaquenil; Retinal outer band; Rheumatoid arthritis

Indexed keywords

HYDROXYCHLOROQUINE; HYDROXYCHLOROQUINE SULFATE;

ADULT; AGED; ARTICLE; BRUCH MEMBRANE; BRUCH MEMBRANE THICKNESS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; HUMAN; MALE; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINAL PIGMENT EPITHELIUM THICKNESS; RETINAL THICKNESS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BRUCH MEMBRANE; FEMALE; HUMANS; HYDROXYCHLOROQUINE; MACULAR DEGENERATION; MALE; MIDDLE AGED; ORGAN SIZE; RETINAL PIGMENT EPITHELIUM; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84879219540     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-012-2256-5     Document Type: Article

References (13)

1. Friedman DS, O'Colmain BJ, Muñoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J, Eye Diseases Prevalence Research Group (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564-572
2. Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134:411-431
3. In't Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Dutjn CM, StijnenT BMM, Stricker BH (2001) Non-steroidal anti inflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 345:1515-1521
4. McGeer PL, Schulzer M, McGeer EG, Sibley J (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease; a review of 17 epidemiological studies. Neurology 47:425-432
5. McGeer PL, Sibley J (2005) Sparing of age-related macular degeneration in rheumatoid arthritis. Neurobiol Aging J 26:1199-1203
6. Cox NH, Paterson WD (1994) Ocular toxicity of antimalarials in dermatology: a survey of current practice. Br J Dermatol 131:878-882
7. Coyle JT (2001) Hydroxychloroquine retinopathy. Ophthalmology 108:243-244
8. Bernstein HN, Ginsberg J (1964) The pathology of chloroquine retinopathy. Arch Ophthalmol 71:238-245
9. Cambiaggi A (1957) Unusual ocular lesions in a case of systemic lupus erythematosus. Arch Ophthalmol 57:451-453
10. Hobbs HE, Sorsby A, Freedman A (1959) Retinopathy following chloroquine therapy. Lancet 2:478-480
11. Korah S, Kuriakose T (2008) Optical coherence tomography in a patient with chloroquine-induced maculopathy. Indian J Ophthalmol 56:511-513
12. Rodriguez-Padilla JA, Hedges TR, Monson B, Srinivasan V, Wojtkowski M, Reichel E, Duker JS, Schuman JS, Fujimoto JG (2007) High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol 125:775-780
13. Ramsey MS, Fine BS (1972) Chloroquine toxicity in the human eye. Histopathologic observations by electron microscopy. Am J Ophthalmol 73:229-235